Taken together, these data suggest that antioxidant treatment may improve plasma membrane repair by reducing mitochondrial ROS levels in FSHD myoblasts independent of any effect on DUX4 expression. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.